Impact of baseline renal function on efficacy and safety of daratumumab plus bortezomib-melphalan-prednisone (VMP) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).

Michele Cavo,Stefan Knop,Mark Cook,Jesus San-Miguel,Meletios A Dimopoulos,Susan Wroblewski,Mario Boccadoro,P Joy Ho,Ming Qi,Sung-Soo Yoon,Ludek Pour,Jianping Wang,Maria-Victoria Mateos,Chantal Doyen,Joan Blade,Kenshi Suzuki,Andrzej J Jakubowiak,William Deraedt,Tamas Masszi

doi:10.1200/jco.2018.36.15_suppl.e20024

Impact of baseline renal function on efficacy and safety of daratumumab plus bortezomib-melphalan-prednisone (VMP) in patients (Pts) with newly diagnosed multiple myeloma (NDMM) ineligible for transplantation (ALCYONE).

Michele Cavo, Stefan Knop + Show 17 more

https://doi.org/10.1200/jco.2018.36.15_suppl.e20024

Copy DOI

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2018
Citations: 3

Affiliation: University of Bologna, University of Würzburg, University Hospitals Birmingham NHS Foundation Trust, Clinica Universidad de Navarra, National and Kapodistrian University of Athens, University of Turin, Royal Prince Alfred Hospital, Janssen (United States), Seoul National University, University Hospital Brno, Université Catholique de Louvain, Hospital Clínic de Barcelona, Japanese Red Cross Medical Center, University of Chicago Medical Center, Janssen (Belgium), Semmelweis University

#Impact Of Baseline Renal Function #Newly Diagnosed Multiple Myeloma + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

e20024Background: In the phase 3 ALCYONE study, daratumumab (D) in combination with VMP (D-VMP) prolonged progression-free survival (PFS) vs VMP alone, and exhibited favorable tolerability in pts w...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.